Source: Eur Respir J 2012; 40: 345-355
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ubhi Baljit K., Riley John H., Shaw Paul A., Lomas David A., Tal-Singer Ruth, MacNee William, Griffin Julian L., Connor Susan C.. Metabolic profiling detects biomarkers of protein degradation in COPD patients. Eur Respir J 2012; 40: 345-355

Member's Comments

No comment yet.

Related content which might interest you: Serum metabolomic analysis of mustard airway diseases by nuclear magnetic resonance spectrometry: A pilot study Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Mass spectrometry proteomic biomarkers identify acute COPD exacerbations Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy Source: Eur Respir J 2008; 32: 1175-1183 Year: 2008 A liquid chromatography MS/MS metabolomics study of COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 A metabonomic approach to prognostic evaluation of ALI by high-resolution nuclear magnetic resonance (HR NMR) spectroscopy Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 Contribution of mass spectrometry (SELDI-TOF-MS) to the analysis of low molecular weight proteins in acute and chronic asthma models Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation Year: 2008 Metabolomic analysis by nuclear magnetic resonance spectroscopy of exhaled breath condensate in patients with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Determination of volatile organic compounds in exhaled breath of patients with chronic obstructive pulmonary disease by gas chromatography mass spectrometry Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Nuclear magnetic resonance and mass spectrometry analysis of exhaled breath condensate Source: Annual Congress 2009 - Noninvasive monitoring of airway inflammation: beyond exhaled nitric oxide Year: 2009 Adaptation of differential ion mobility spectrometry (DMS) for discrimination of specific biomarkers in exhaled breath in patients with severe renal-pulmonary dysfunction Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 LSC - 2018 - Characterization of decellularized COPD lung matrices using mass spectrometry proteomics Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018 Metabonomic analysis of EBC in adults by nuclear magnetic resonance spectroscopy Source: Annual Congress 2008 - New frontiers in noninvasive assessment of the lungs Year: 2008 Methodological issues of sample collection and analysis of exhaled breath Source: Eur Respir Monogr 2010; 49: 96-114 Year: 2010 Desmosine as a biomarker of elastin degradation in COPD: current status and future directions Source: Eur Respir J 2008; 32: 1146-1157 Year: 2008 Breath analysis in real time by mass spectrometry in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013 Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 The study of proton magnetic resonance spectroscopy on hippocampus in rats with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Development of mass spectrometry approaches to quantifying lipid mediators in airway disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients. Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Metabonomic approach for noninvasive diagnosis of inflammatory lung diseases through nuclear magnetic resonance analysis of exhaled breath condensate Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007